http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TN-2013000035-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
filingDate 2013-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_697b8e345c5583d8e84991a51445c726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9e3f8b3303f17ddda2c2004e56505a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59003294805e9ccec01bce2925397c0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_653e83ee93aa0f2e248811ea8e1a75ca
publicationDate 2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TN-2013000035-A1
titleOfInvention Highly crystalline valsartan
abstract The present invention describes a highly crystalline form of valsartan, pharmaceutical compositions thereof and process for the preparation thereof
priorityDate 2011-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60846

Total number of triples: 17.